SLED Opportunity · NEW YORK · NEW YORK
AI Summary
New York State seeks to obtain the specialty medication Trikafta to treat cystic fibrosis in an at-risk youth in custody. This breakthrough drug improves symptoms and slows disease progression.
OCFS has the need to obtain the medication Trikafta in order to treat Cystic Fibrosis for an at-risk youth in custody. Trikafta treats the mutation causing cystic fibrosis. It not only improves symptoms but slows the progression of the disease overall. It has been a breakthrough medication for people with cystic fibrosis, allowing them to plan on living longer and to participate in life more fully. Trikafta is a specialty medication that can only be filled by a specialty pharmacy.
SLED stands for State, Local, and Education. These are solicitations issued by state governments, counties, cities, school districts, utilities, and higher education institutions — as opposed to federal agencies.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.